ARHGEF3 reduces its acetylation on Lys17 and Lys86, leading to protein homeostasis of ACLY and dissociation between ACLY and its E3 ligase NEDD4, thereby affecting lung cancer progression. This evidence concerns the gene NEDD4 and lung cancer.